LGR5 is expressed by Ewing sarcoma and potentiates Wnt/β-catenin signaling

Frontiers in Oncology

Volumn 3 APR, Issue , 2013, Pages

  Scannell, Christopher A ^a,b   Pedersen, Elisabeth A ^b   Mosher, Jack T ^b   Krook, Melanie Anne ^b   Nicholls, Lauren A ^b   Wilky, Breelyn A ^c   Loeb, David M ^d   Lawlor, Elizabeth R ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

catenin; Ewing sarcoma; LGR5; R spondin; Stem cell; Wnt

Indexed keywords

BETA CATENIN; G PROTEIN COUPLED RECEPTOR KINASE 5;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE FREE SURVIVAL; EWING SARCOMA; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT TANDEM REPEAT; WNT SIGNALING PATHWAY;

EID: 84890687876     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00081     Document Type: Article

References (64)

1. Awad, O., Yustein, J. T., Shah, P., Gul, N., Katuri, V., O'Neill, A., et al. (2010). High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. PLoS ONE 5:e13943. doi:10.1371/journal.pone.0013943
2. Balamuth, N. J., and Womer, R. B. (2010). Ewing's sarcoma. Lancet Oncol. 11, 184-192.
3. Balamuth, N. J., Wood, A., Wang, Q., Jagannathan, J., Mayes, P., Zhang, Z., et al. (2010). Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Res. 70, 2749-2758.
4. Barker, N., and Clevers, H. (2010). Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology 138, 1681-1696.
5. Barker, N., Huch, M., Kujala, P., Van De Wetering, M., Snippert, H. J., Van Es, J. H., et al. (2010). Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6, 25-36.
6. Barker, N., Ridgway, R. A., Van Es, J. H., Van De Wetering, M., Begthel, H., Van Den Born, M., et al. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611.
7. Barker, N., Rookmaaker, M. B., Kujala, P., Ng, A., Leushacke, M., Snippert, H., et al. (2012). Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep. 2, 540-552.
8. Barker, N., Van Es, J. H., Kuipers, J., Kujala, P., Van Den Born, M., Cozijnsen, M., et al. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-1007.
9. Barretina, J., Taylor, B. S., Banerji, S., Ramos, A. H., Lagos-Quintana, M., Decarolis, P. L., et al. (2010). Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat. Genet. 42, 715-721.
10. Bauer, L., Langer, R., Becker, K., Hapfelmeier, A., Ott, K., Novotny, A., et al. (2012). Expression profiling of stem cell-related genes in neoadjuvant-treated gastric cancer: a NOTCH2, GSK3B and beta-catenin gene signature predicts survival. PLoS ONE 7:e44566. doi:10.1371/journal.pone.0044566
11. Becker, L., Huang, Q., and Mashimo, H. (2010). Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma. Dis. Esophagus 23, 168-174.
12. Ben-Porath, I., Thomson, M. W., Carey, V. J., Ge, R., Bell, G. W., Regev, A., et al. (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40, 499-507.
13. Carmon, K. S., Gong, X., Lin, Q., Thomas, A., and Liu, Q. (2011). R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc. Natl. Acad. Sci. U.S.A. 108, 11452-11457.
14. Chan, T. A., Glockner, S., Yi, J. M., Chen, W., Van Neste, L., Cope, L., et al. (2008). Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 5:e114. doi:10.1371/journal.pmed.0050114
15. Clevers, H., and Nusse, R. (2012). Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205.
16. Cui, W., Taub, D. D., and Gardner, K. (2007). qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res. 35, D805-809.
17. de Lau, W., Barker, N., Low, T. Y., Koo, B. K., Li, V. S., Teunissen, H., et al. (2011). Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476, 293-297.
18. de Sousa, E. M. F., Colak, S., Buikhuisen, J., Koster, J., Cameron, K., De Jong, J. H., et al. (2011). Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 9, 476-485.
19. Endo, Y., Beauchamp, E., Woods, D., Taylor, W. G., Toretsky, J. A., Uren, A., et al. (2008). Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3-and c-Jun N-terminal kinase-dependent mechanism. Mol. Cell. Biol. 28, 2368-2379.
20. Feldhahn, N., Henke, N., Melchior, K., Duy, C., Soh, B. N., Klein, F., et al. (2007). Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J. Exp. Med. 204, 1157-1166.
21. Friedman, M. S., Oyserman, S. M., and Hankenson, K. D. (2009). Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2. J. Biol. Chem. 284, 14117-14125.
22. Fuerer, C., and Nusse, R. (2010). Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS ONE 5:e9370. doi:10.1371/journal.pone.0009370
23. Glinka, A., Dolde, C., Kirsch, N., Huang, Y. L., Kazanskaya, O., Ingelfinger, D., et al. (2011). LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep. 12, 1055-1061.
24. Gong, X., Carmon, K. S., Lin, Q., Thomas, A., Yi, J., and Liu, Q. (2012). LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS ONE 7:e37137. doi:10.1371/journal.pone.0037137
25. Hankenson, K. D., Sweetwyne, M. T., Shitaye, H., and Posey, K. L. (2010). Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling. Curr. Osteoporos. Rep. 8, 68-76.
26. Hauer, K., Calzada-Wack, J., Steiger, K., Grunewald, T. G., Baumhoer, D., Plehm, S., et al. (2013). DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma. Cancer Res. 73, 967-977.
27. Jaks, V., Barker, N., Kasper, M., Van Es, J. H., Snippert, H. J., Clevers, H., et al. (2008). Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat. Genet. 40, 1291-1299.
28. Jiang, M., Stanke, J., and Lahti, J. M. (2011). The connections between neural crest development and neuroblastoma. Curr. Top. Dev. Biol. 94, 77-127.
29. Jiang, X., Gwye, Y., McKeown, S. J., Bronner-Fraser, M., Lutzko, C., and Lawlor, E. R. (2009). Isolation and characterization of neural crest stem cells derived from in vitro-differentiated human embryonic stem cells. Stem Cells Dev. 18, 1059-1070.
30. Jiang, X., Gwye, Y., Russell, D., Cao, C., Douglas, D., Hung, L., et al. (2010). CD133 expression in chemo-resistant Ewing sarcoma cells. BMC Cancer 10:116. doi:10.1186/1471-2407-10-116
31. Jin, Z., Zhao, C., Han, X., and Han, Y. (2012). Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression. BMC Cancer 12:480. doi:10.1186/1471-2407-12-480
32. Kawauchi, D., Robinson, G., Uziel, T., Gibson, P., Rehg, J., Gao, C., et al. (2012). A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 21, 168-180.
33. Kemper, K., Prasetyanti, P. R., De Lau, W., Rodermond, H., Clevers, H., and Medema, J. P. (2012). Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells 30, 2378-2386.
34. Kobayashi, S., Yamada-Okabe, H., Suzuki, M., Natori, O., Kato, A., Matsubara, K., et al. (2012). LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Stem Cells 30, 2631-2644.
35. McClanahan, T., Koseoglu, S., Smith, K., Grein, J., Gustafson, E., Black, S., et al. (2006). Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol. Ther. 5, 419-426.
36. Meltzer, P. S. (2007). Is Ewing's sarcoma a stem cell tumor? Cell Stem Cell 1, 13-15.
37. Merlos-Suarez, A., Barriga, F. M., Jung, P., Iglesias, M., Cespedes, M. V., Rossell, D., et al. (2011). The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 8, 511-524.
38. Miyagawa, Y., Okita, H., Itagaki, M., Toyoda, M., Katagiri, Y. U., Fujimoto, J., et al. (2009). EWS/ETS regulates the expression of the Dickkopf family in Ewing family tumor cells. PLoS ONE 4:e4634. doi:10.1371/journal.pone.0004634
39. Nagoshi, N., Shibata, S., Kubota, Y., Nakamura, M., Nagai, Y., Satoh, E., et al. (2008). Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2, 392-403.
40. Nakata, S., Campos, B., Bageritz, J., Lorenzo Bermejo, J., Becker, N., Engel, F., et al. (2013). LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol. 23, 60-72.
41. Nam, J. S., Turcotte, T. J., and Yoon, J. K. (2007). Dynamic expression of R-spondin family genes in mouse development. Gene Expr. Patterns 7, 306-312.
42. Navarro, D., Agra, N., Pestana, A., Alonso, J., and Gonzalez-Sancho, J. M. (2010). The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription. Carcinogenesis 31, 394-401.
43. Phillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., et al. (2006). Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173.
44. Riggi, N., Suva, M. L., Suva, D., Cironi, L., Provero, P., Tercier, S., et al. (2008). EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 68, 2176-2185.
45. Rot, S., Taubert, H., Bache, M., Greither, T., Wurl, P., Eckert, A. W., et al. (2011). A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients. BMC Cancer 11:429. doi:10.1186/1471-2407-11-429
46. Schepers, A. G., Snippert, H. J., Stange, D. E., Van Den Born, M., Van Es, J. H., Van De Wetering, M., et al. (2012). Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730-735.
47. Simon, E., Petke, D., Boger, C., Behrens, H. M., Warneke, V., Ebert, M., et al. (2012). The spatial distribution of LGR5+ cells correlates with gastric cancer progression. PLoS ONE 7:e35486. doi:10.1371/journal.pone.0035486
48. Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274.
49. Spike, B. T., Engle, D. D., Lin, J. C., Cheung, S. K., La, J., and Wahl, G. M. (2012). A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 10, 183-197.
50. Staege, M. S., Hutter, C., Neumann, I., Foja, S., Hattenhorst, U. E., Hansen, G., et al. (2004). DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res. 64, 8213-8221.
51. Suva, M. L., Riggi, N., Stehle, J. C., Baumer, K., Tercier, S., Joseph, J. M., et al. (2009). Identification of cancer stem cells in Ewing's sarcoma. Cancer Res. 69, 1776-1781.
52. Takahashi, H., Ishii, H., Nishida, N., Takemasa, I., Mizushima, T., Ikeda, M., et al. (2011). Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann. Surg. Oncol. 18, 1166-1174.
53. Takashima, Y., Era, T., Nakao, K., Kondo, S., Kasuga, M., Smith, A. G., et al. (2007). Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 129, 1377-1388.
54. Tanese, K., Fukuma, M., Yamada, T., Mori, T., Yoshikawa, T., Watanabe, W., et al. (2008). G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. Am. J. Pathol. 173, 835-843.
55. Tirode, F., Laud-Duval, K., Prieur, A., Delorme, B., Charbord, P., and Delattre, O. (2007). Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11, 421-429.
56. Uchida, H., Yamazaki, K., Fukuma, M., Yamada, T., Hayashida, T., Hasegawa, H., et al. (2010). Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci. 101, 1731-1737.
57. Uren, A., Wolf, V., Sun, Y. F., Azari, A., Rubin, J. S., and Toretsky, J. A. (2004). Wnt/Frizzled signaling in Ewing sarcoma. Pediatr. Blood Cancer 43, 243-249.
58. Valladares-Ayerbes, M., Blanco-Calvo, M., Reboredo, M., Lorenzo-Patino, M. J., Iglesias-Diaz, P., Haz, M., et al. (2012). Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer. Int. J. Mol. Sci. 13, 4367-4387.
59. Vijayakumar, S., Liu, G., Rus, I. A., Yao, S., Chen, Y., Akiri, G., et al. (2011). High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A. Cancer Cell 19, 601-612.
60. Visvader, J. E., and Lindeman, G. J. (2012). Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717-728.
61. von Levetzow, C., Jiang, X., Gwye, Y., Von Levetzow, G., Hung, L., Cooper, A., et al. (2011). Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS ONE 6:e19305. doi:10.1371/journal.pone.0019305
62. Walker, F., Zhang, H. H., Odorizzi, A., and Burgess, A. W. (2011). LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS ONE 6:e22733. doi:10.1371/journal.pone.0022733
63. Wislet-Gendebien, S., Laudet, E., Neirinckx, V., Alix, P., Leprince, P., Glejzer, A., et al. (2012). Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell. Mol. Life Sci. 69, 2593-2608.
64. Wu, X.-S., Xi, H.-Q., and Chen, L. (2012). Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J. Surg. Oncol. 10, 244.